These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1871802)

  • 1. Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation.
    Le Mauff B; Hourmant M; Rougier JP; Hirn M; Dantal J; Baatard R; Cantarovich D; Jacques Y; Soulillou JP
    Transplantation; 1991 Aug; 52(2):291-6. PubMed ID: 1871802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot study.
    Cantarovich D; Le Mauff B; Hourmant M; Giral M; Denis M; Hirn M; Jacques Y; Soulillou JP
    Transplantation; 1989 Mar; 47(3):454-7. PubMed ID: 2646778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-searching trial of an anti-LFA1 monoclonal antibody in first kidney transplant recipients.
    Le Mauff B; Le Meur Y; Hourmant M; Debray M; Boeffard F; Alberici G; Soulillou JP; Scherrmann JM
    Kidney Int Suppl; 1996 Jan; 53():S44-50. PubMed ID: 8770990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD4 MoAb therapy in kidney transplantation--a pilot study in early prophylaxis of rejection.
    Dantal J; Ninin E; Hourmant M; Boeffard F; Cantarovich D; Giral M; Wijdenes J; Soulillou JP; Le Mauff B
    Transplantation; 1996 Nov; 62(10):1502-6. PubMed ID: 8958279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.
    Maraninchi D; Mawas C; Stoppa AM; Gaspard MH; Marit G; Van Ekthoven A; Reiffers J; Olive D; Hirn M; Delaage M
    Bone Marrow Transplant; 1989 Mar; 4(2):147-50. PubMed ID: 2650783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation. A pilot study.
    Hourmant M; Le Mauff B; Le Meur Y; Dantal J; Cantarovich D; Giral M; Caudrelier P; Albericci G; Soulillou JP
    Transplantation; 1994 Aug; 58(3):377-80. PubMed ID: 8053064
    [No Abstract]   [Full Text] [Related]  

  • 7. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.
    Transplantation; 1997 May; 63(9):1243-51. PubMed ID: 9158016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation.
    Hourmant M; Le Mauff B; Cantarovich D; Dantal J; Baatard R; Denis M; Jacques Y; Karam G; Soulillou JP
    Transplantation; 1994 Jan; 57(2):204-7. PubMed ID: 8310508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody treatment (anti-CD4 and anti-interleukin-2 receptor) combined with cyclosporin A has a positive but not simple dose-dependent effect on rat renal allograft survival.
    Steinbrüchel DA; Koch C; Kristensen T; Kemp E
    Scand J Immunol; 1991 Nov; 34(5):627-33. PubMed ID: 1947798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations.
    Hourmant M; Bedrossian J; Durand D; Lebranchu Y; Renoult E; Caudrelier P; Buffet R; Soulillou JP
    Transplantation; 1996 Dec; 62(11):1565-70. PubMed ID: 8970608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation: a case report.
    Jirasiritham S; Khunprakant R; Techawathanawanna N; Jirasiritham S; Mavichak V
    Transplant Proc; 2010 Apr; 42(3):987-9. PubMed ID: 20430222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local immunosuppressive therapy with monoclonal anti-T cell antibody on renal allograft survival in the rat.
    Lee CJ; Yoshimura N; Shiho O; Kita M; Oka T
    Clin Exp Immunol; 1993 Mar; 91(3):362-7. PubMed ID: 7680292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.
    Bühler L; Yamada K; Kitamura H; Alwayn IP; Basker M; Appel JZ; Colvin RB; White-Scharf ME; Sachs DH; Robson SC; Awwad M; Cooper DK
    Transplantation; 2001 Dec; 72(11):1743-52. PubMed ID: 11740383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
    Woodle ES; Xu D; Zivin RA; Auger J; Charette J; O'Laughlin R; Peace D; Jollife LK; Haverty T; Bluestone JA; Thistlethwaite JR
    Transplantation; 1999 Sep; 68(5):608-16. PubMed ID: 10507477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation.
    Vincenti F; Mendez R; Pescovitz M; Rajagopalan PR; Wilkinson AH; Butt K; Laskow D; Slakey DP; Lorber MI; Garg JP; Garovoy M
    Am J Transplant; 2007 Jul; 7(7):1770-7. PubMed ID: 17564637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.